Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4U: L-Thyroxine for the treatment of acute unilateral vestibulopathy
2024-519515-34-00Phase 2Authorised
- Sponsor
- LMU Klinikum
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vestibular neuritis comparing L-thyroxine plus standard methylprednisolone with Placebo plus standard methylprednisolone (2 arms). Planned start Jun 2026; status: authorised.
02
Drugs
levothyroxine sodium
03
Conditions
vestibular neuritis
Beyond the preview
Go deeper on 2024-519515-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519515-34-00.